SNDX
Syndax Pharmaceuticals Inc
NASDAQ: SNDX · HEALTHCARE · BIOTECHNOLOGY
$20.65
+2.74% today
Updated 2026-05-06
Market cap
$1.69B
P/E ratio
—
P/S ratio
7.79x
EPS (TTM)
$-2.79
Dividend yield
—
52W range
$9 – $26
Volume
1.6M
Syndax Pharmaceuticals Inc (SNDX) Financial statements
SEC filings — annual and quarterly data.
Balance sheet — annual
| Item |
|---|
| Total assets |
| Cash & equivalents |
| Current assets |
| Total liabilities |
| Current liabilities |
| Long-term debt |
| Shareholder equity |
| Retained earnings |
| Accounts receivable |
| Inventory |
| Goodwill |